<?xml version="1.0" encoding="UTF-8"?>
<ref id="R90">
 <label>90.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Parikh</surname>
    <given-names>SA</given-names>
   </name>
   <name>
    <surname>Achenbach</surname>
    <given-names>SJ</given-names>
   </name>
   <name>
    <surname>Call</surname>
    <given-names>TG</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice</article-title>. 
  <source>
   <italic toggle="yes">Cancer Med.</italic>
  </source>
  <year>2020</year>;
  <volume>9</volume>:
  <fpage>3390</fpage>â€“
  <lpage>3399</lpage>.
  <pub-id pub-id-type="pmid">32187452</pub-id>
 </mixed-citation>
</ref>
